Thermo Fisher Scientific Inc. (TMO)
NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 574.59 |
| 開市 | 578.00 |
| 買盤 | 0.00 x 800 |
| 賣出價 | 0.00 x 800 |
| 今日波幅 | 565.23 - 586.46 |
| 52 週波幅 | 415.60 - 603.82 |
| 成交量 | |
| 平均成交量 | 1,460,758 |
| 市值 | 220.398B |
| Beta 值 (5 年，每月) | 0.80 |
| 市盈率 (最近 12 個月) | 37.35 |
| 每股盈利 (最近 12 個月) | 15.46 |
| 業績公佈日 | 2024年7月24日 - 2024年7月29日 |
| 遠期股息及收益率 | 1.56 (0.27%) |
| 除息日 | 2024年3月14日 |
| 1 年預測目標價 | 609.83 |
Motley FoolThermo Fisher Scientific (TMO) Q1 2024 Earnings Call Transcript
TMO earnings call for the period ending March 31, 2024.
ZacksThermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
BenzingaThermo Fisher Lifts Annual Forecast On Improved Demand, Despite Q1 Revenue Dip
On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted a first-quarter revenue of $10.34 billion, down 3% year over year, beating the consensus of $10.17 billion. Organic revenue was 4% lower, and core organic revenue growth declined by 3%. Revenue from the Life Sciences Solutions Segment declined by 12.5% to $2.29 billion. Analytical Instruments Segment sales were down 2.1% to $1.69 billion. Specialty Diagnostics Segment revenues were almost flat at $1.1 billion, and Laboratory Products
